Annual Operating Expenses
$126.04 M
+$32.62 M+34.92%
December 31, 2023
Summary
- As of February 8, 2025, VOR annual total operating expenses is $126.04 million, with the most recent change of +$32.62 million (+34.92%) on December 31, 2023.
- During the last 3 years, VOR annual operating expenses has risen by +$82.67 million (+190.63%).
- VOR annual operating expenses is now at all-time high.
Performance
VOR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$28.51 M
-$522.00 K-1.80%
September 30, 2024
Summary
- As of February 8, 2025, VOR quarterly total operating expenses is $28.51 million, with the most recent change of -$522.00 thousand (-1.80%) on September 30, 2024.
- Over the past year, VOR quarterly operating expenses has increased by +$389.00 thousand (+1.38%).
- VOR quarterly operating expenses is now -19.26% below its all-time high of $35.32 million, reached on September 30, 2023.
Performance
VOR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VOR Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.9% | +1.4% |
| 3 y3 years | +190.6% | +1.4% |
| 5 y5 years | +4306.9% | +1.4% |
VOR Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +82.6% | -19.3% | +55.8% |
| 5 y | 5-year | at high | +1109.9% | -19.3% | +625.9% |
| alltime | all time | at high | +4306.9% | -19.3% | +625.9% |
Vor Biopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $28.51 M(-1.8%) |
| Jun 2024 | - | $29.04 M(-10.2%) |
| Mar 2024 | - | $32.33 M(+14.9%) |
| Dec 2023 | $126.04 M(+34.9%) | $28.12 M(-20.4%) |
| Sep 2023 | - | $35.32 M(+9.8%) |
| Jun 2023 | - | $32.17 M(+5.8%) |
| Mar 2023 | - | $30.42 M(+23.0%) |
| Dec 2022 | $93.42 M | $24.73 M(+2.6%) |
| Sep 2022 | - | $24.10 M(+10.6%) |
| Jun 2022 | - | $21.79 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $22.80 M(+24.5%) |
| Dec 2021 | $69.02 M(+59.2%) | $18.31 M(-1.6%) |
| Sep 2021 | - | $18.60 M(+1.2%) |
| Jun 2021 | - | $18.38 M(+33.9%) |
| Mar 2021 | - | $13.73 M(-12.3%) |
| Dec 2020 | $43.37 M(+316.3%) | $15.66 M(+32.9%) |
| Sep 2020 | - | $11.79 M(+46.6%) |
| Jun 2020 | - | $8.04 M(+2.1%) |
| Mar 2020 | - | $7.88 M(+100.6%) |
| Dec 2019 | $10.42 M(+264.2%) | $3.93 M |
| Dec 2018 | $2.86 M | - |
FAQ
- What is Vor Biopharma annual total operating expenses?
- What is the all time high annual operating expenses for Vor Biopharma?
- What is Vor Biopharma annual operating expenses year-on-year change?
- What is Vor Biopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Vor Biopharma?
- What is Vor Biopharma quarterly operating expenses year-on-year change?
What is Vor Biopharma annual total operating expenses?
The current annual operating expenses of VOR is $126.04 M
What is the all time high annual operating expenses for Vor Biopharma?
Vor Biopharma all-time high annual total operating expenses is $126.04 M
What is Vor Biopharma annual operating expenses year-on-year change?
Over the past year, VOR annual total operating expenses has changed by +$32.62 M (+34.92%)
What is Vor Biopharma quarterly total operating expenses?
The current quarterly operating expenses of VOR is $28.51 M
What is the all time high quarterly operating expenses for Vor Biopharma?
Vor Biopharma all-time high quarterly total operating expenses is $35.32 M
What is Vor Biopharma quarterly operating expenses year-on-year change?
Over the past year, VOR quarterly total operating expenses has changed by +$389.00 K (+1.38%)